Neurocrine(NBIX) - 2021 Q2 - Earnings Call Transcript

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q2 2021 Results Conference Call August 3, 2021 4:30 PM ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO Matt Abernethy - CFO Eiry Roberts - Chief Medical Officer Eric Benevich - Chief Commercial Officer Kyle Gano - Chief Business Development and Strategy Officer Conference Call Participants Tazeen Ahmad - Bank of America Phil Nadeau - The Cowen Company Paul Matteis - Stifel Brian Abrahams - RBC Capital Markets Brian Skorney - Baird Jay Olson - Oppenh ...